[1] Patwari P, Higgins LJ, Chutkow WA, et al.The interaction of thioredoxin with Txnip.Evidence for formation of a mixed disulfide by disulfide exchange[J].J Biol Chem, 2006, 281(31):21884-21891.[2] Zhou JB, Yu Q, Chng WJ.TXNIP (VDUP-1, TBP-2):A major redox regulator commonly suppressed in cancer[J].Int J Biochem Cell Biol, 2011, 43(12):1668-1673.[3] Kaimul AM, Nakamura H, Masutani H, et al. Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome[J].Free Radical Biol Med, 2007, 43(6):861-868.[4] Kwon HJ, Won YS, Suh HW, et al.Vitamin D3 upregulated protein 1 suppresses TNF-alpha-induced NF-kappaB activation in hepatocarcinogenesis[J].J Immunol, 2010, 185(7):3980-3989.[5] Nishizawa K, Nishiyama H, Matsui Y, et al.Thioredoxin-interacting protein suppresses bladder carcinogenesis [J].Carcinogenesis, 2011, 32(10):1459-1466.[6] Morrison JA, Pike LA, Sams SB, et al.Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in thyroid cancer[J].Mol Cancer, 2014, 13(1):1-13.[7] Zhou J, Bi C, Cheong LL, et al.The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML[J].Blood, 2011, 118(10):2830-2839.[8] Kwon HJ, Won YS, Nam KT, et al.Vitamin D3upregulated protein 1 deficiency promotes N-methyl-N-nitrosourea and Helicobacter pylori-induced gastric carcinogenesis in mice[J].Gut, 2012, 61(1):53-63.[9] Holmgren A, Johansson C, Berndt C, et al.Thiol redox control via thioredoxin and glutaredoxin systems[J].Biochem Soc Trans, 2005, 33(pt 6):1375-1377.[10] Le Bras M, Clement MV, Pervaiz S, et al.Reactive oxygen species and the mito-chondrial signaling pathway of cell death[J].Histol Histopathol, 2005, 20(1):205-219.[11] Kim SY, Suh HW, Chung JW, et al.Diverse functions of VDUP1 in cell proliferation, differen tiation, and diseases[J].Cell Mol Immunol, 2007, 4(5):345 -351.[12] Watanabe R, Nakamura H, Masutani H, et al.Anti-oxidative, anti-cancer and anti-inflammatory actions by thioredoxin 1 and thioredoxin-binding protein-2[J].Pharmacol Ther, 2010, 127(3):261-270.[13] Yoshihara E, Chen Z, Matsuo Y, et al.Thiol redox transitions by thioredoxin and thioredoxin-bind ing protein-2 in cell signaling[J].Methods Enzymol, 2010, 474(1):67-82.[14] Elgort MG, O'Shea JM, Jiang Y, et al.Transcriptional and translational downregulation of thioredoxin interacting protein is required for metabolic reprogramming during G(1)[J].Genes Cancer, 2010, 1(9):893-907.[15] Lim JY, Yoon SO, Hong SW, et al.thioredoxin and thioredoxin-interacting protein as prognostic markers for gastric cancer recurrence[J].World J Gastroenterol, 2012, 18(39):5581-5588.[16] Zhang L, Hou YH, Wu K, et al.proteomic analysis reveals molecular biological details in varioliform gastritis without Helicobacter pylori infection[J].World J Gastroenterol, 2010, 16(29):3664-3673. |